May 9, 2012
|
Journal Article
Drug withdrawal in infants born to opiate-abusing mothers—Neonatal Abstinence Syndrome (NAS)—is increasingly prevalent. The study examines the dramatic rise in NAS, and the increase in hospital charges over a 10-year period.
April 1, 2001
|
Program Result
Starting in October 1995, Temple University Hospital expanded a pilot program to address infant mortality in North Philadelphia and provide a full range of primary care and preventive services.
April 1, 1997
|
Program Result
The University of Iowa College of Medicine developed an ongoing statewide survey in Iowa to assess barriers to obtaining prenatal care.
November 1, 2001
|
Program Result
The University of North Carolina at Chapel Hill School of Public Health convened a blue ribbon panel to develop a strategic plan to encourage women of childbearing age to increase their intake of folate and folic acid.
April 30, 2012
|
Story
Study by RWJF scholar finds big increases in women on opiate drugs while pregnant, and newborns suffering withdrawal.
January 1, 2002
|
Book
This chapter in the Robert Wood Johnson Foundation's Anthology V, examines nurse visitation programs to disadvantaged first-time mothers during and after their pregnancies.
December 1, 2009
|
Journal Article
This article examines the experience of female Somali immigrants with the United States medical system, and focuses on reproductive health care. The authors used interviews, focus groups and surveys to identify challenges to care for Somali women.
May 3, 2012
|
Story
The timely intervention of a specially trained nurse held the potential to change the lives of poor young mothers and their babies for the better ... not just in the near term, but for many years to come.
October 15, 2007
|
Story
"Against all odds, our community health leaders continue to remind us of the difference that one person can make and we are exceedingly proud of their endeavors," says Judith Stavisky, MPH, MEd, RWJF senior program officer.
October 29, 2007
|
Story
Via the Internet, ARCHeS will dramatically expand access to Archimedes, a powerful medical outcomes predictive model.